A comprehensive resource list for biotech founders and researchers seeking capital without equity dilution, covering government grants, philanthropic awards, and competitive prize mechanisms essential for early-stage validation and clinical development.
Get targeted exposure with custom position pinning and highlighted placement.
The primary source of biomedical research funding in the US, offering SBIR/STTR mechanisms specifically designed to help small businesses translate scientific discoveries into viable therapeutic products. These grants provide critical early-stage capital for proof-of-concept work.
A federal program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. It provides phased funding with significant milestone-based financial support for high-risk biotech innovations.
Similar to SBIR but requires a formal research partnership with a non-profit research institution, such as a university or federal laboratory. This program is ideal for biotech startups leveraging academic research while sharing risk and resources.
An initiative that coordinates small business innovation efforts across multiple federal agencies, including FDA and DoD. It helps biotech companies navigate complex regulatory and funding landscapes by aligning federal support with commercialization goals.
Offers large-scale prize competitions for global health innovations, providing substantial funding to teams developing solutions for infectious diseases, maternal health, and sanitation. Ideal for biotech firms addressing unmet medical needs in developing regions.
Provides unrestricted funding and collaborative opportunities for scientists and engineers working on biology-related challenges. Their open science approach supports high-risk, high-reward research that traditional grants might overlook.
The Defense Advanced Research Projects Agency funds disruptive biological technologies with potential national security or medical applications. They offer unique opportunities for biotech firms developing diagnostics, therapeutics, or bio-defense tools.
Specifically targets cancer research innovations, offering tailored funding opportunities for small businesses developing novel cancer prevention, detection, or treatment technologies. Highly relevant for oncology-focused biotech startups.
Funds research that helps people make informed health decisions by comparing the benefits and harms of prevention, diagnosis, treatment, and management strategies. Useful for biotech companies focusing on clinical utility and patient outcomes.
Provides funding for groundbreaking immunotherapy research, supporting early-career scientists and established researchers alike. These awards help bridge the gap between preclinical discovery and clinical application in cancer immunology.
Supports innovative research in neuroscience and neurodegenerative diseases, offering grants to researchers and institutions developing new therapies for conditions like Alzheimer's and Parkinson's disease.
Offers substantial multi-year funding for established biomedical researchers to pursue ambitious, transformative projects. Ideal for senior scientists leading biotech spin-outs or academic ventures with strong clinical potential.
Provides significant funding for early-career researchers in Europe to establish independent research teams. Essential for European biotech founders seeking to validate scientific hypotheses before scaling commercially.
The EU's key funding program supporting innovation in health, digital, and industrial sectors. It offers large-scale collaborative grants for biotech projects that contribute to European strategic autonomy and health resilience.
Recognizes and funds innovative projects in pharmaceutical research and development, particularly those addressing unmet medical needs. Provides both financial support and visibility for early-stage biotech innovations.
Offers competitive grants to support innovative research into the causes, treatment, and prevention of Alzheimer's disease. A key resource for biotech firms focusing on neurodegenerative disorders and cognitive health.
Funds research aimed at preventing birth defects, preterm birth, and infant mortality. Suitable for biotech companies developing reproductive health technologies, neonatal care solutions, or genetic screening tools.
While not a traditional grant, the TED Prize offers $1 million to be spent on a wish that can change the world. Many biotech innovators have used this platform to launch groundbreaking research initiatives and attract subsequent funding.
Awards are given for significant advances in the understanding of living systems. While primarily recognition, associated prizes and networking opportunities can open doors to non-dilutive investment and strategic partnerships.
Supports social impact projects using technology, including health tech and biotech solutions for global health challenges. Offers funding and technical expertise to scale innovative health interventions in underserved communities.